Prosecution Insights
Last updated: May 29, 2026

UNIVERSITY OF ULSAN FOUNDATION FOR INDUSTRY COOPERATION

11 pending office actions • 10 art units • 11 examiners • 0 of 11 (0%) have an AI response strategy ready • 10 patents granted in the last 365 days

Portfolio Summary

11
Total Pending OAs
8
Non-Final OAs
2
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 11 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

5
Overdue
0
Due this week
5
Due this month
1
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 11 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (5)Due ≤ 30 days (5)Due ≤ 60 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (9%)
9
Medium (82%)
1
Easy (9%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only1 (9%)
§103 only9 (82%)
§112 only1 (9%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

5
Life Sciences
45% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
1
Semiconductors
9% of docket
5
Mechanical / Eng
45% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

110 h
Manual time on pending OAs
22 h
Time saved (low, 20%)
38 h
Time saved (mid, 35%)
1.0 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
NGUYEN, VI X 1 85.9% +13.3%
NGUYEN, TRAN N 1 62.0% +16.9%
PAULUS, ERIN VIRGINIA 1 37.5% +83.3%
WILLSE, DAVID H 1 67.5% +13.2%
YU, DELPHINUS DOU YI 1 0.0% +0.0%
HAYNES, DAWN TRINAH 1 2.9% +0.7%
LEE, DA WEI 1 77.8% +19.4%
NGO, MEAGAN N 1 58.2% +31.4%
MEJIAS, SAMANTHA LEE 1 47.4% +62.5%
SANFORD, DIANA PATRICIA 1 83.3% +25.0%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18797333 PACEMAKER LEAD FOR CERCLAGE PACING NGUYEN, VI X 28d overdue

Hard Cases (3)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
17429343 BLOOD CELL-FREE DNA-BASED METHOD FOR PREDICTING PROGNOSIS OF LIVER CANCER TREATMENT SANFORD, DIANA PATRICIA 128d overdue
18249016 PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF RETINAL OR CHOROIDAL DISEASE COMPRISING PLVAP AS ACTIVE INGREDIENT YU, DELPHINUS DOU YI 23d
18004585 APPARATUS, METHOD, AND COMPUTER-READABLE STORAGE MEDIUM FOR SELECTING CLINICAL TRIAL SUBJECT HAYNES, DAWN TRINAH 28d

Interview Candidates (8)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17429343 BLOOD CELL-FREE DNA-BASED METHOD FOR PREDICTING PROGNOSIS OF LIVER CANCER TREATMENT SANFORD, DIANA PATRICIA 128d overdue
18797333 PACEMAKER LEAD FOR CERCLAGE PACING NGUYEN, VI X 28d overdue
18438563 APPARATUS AND METHOD FOR PREDICTING HYPOTENSION BASED ON ARTERIAL PRESSURE WAVELET TRANSFORMATION, AND METHOD FOR TRAINING HYPOTENSION PREDICTION MODEL NGUYEN, TRAN N 17d overdue
18058956 NANOSTRUCTURE-BASED SUBSTRATE FOR SURFACE-ENHANCED RAMAN SPECTROSCOPY, AND MANUFACTURING METHOD THEREFOR LEE, DA WEI 4d overdue
18352493 ARTIFICIAL BLOOD VESSEL COMPLEX WILLSE, DAVID H 14d
18056766 RECTUM EXPANDING BALLOON CATHETER NGO, MEAGAN N 14d
18262341 STEM CELL IN WHICH IMMUNE CELL TOLERANCE MODULATOR IS OVEREXPRESSED, AND USE THEREOF PAULUS, ERIN VIRGINIA 20d
17995024 STABILIZER FOR RADIOPHARMACEUTICALS AND RADIOPHARMACEUTICAL COMPOSITION COMPRISING THE SAME MEJIAS, SAMANTHA LEE 56d

Top Art Units

Art UnitApps
1687 2
3771 1
3685 1
1631 1
3774 1
1636 1
3686 1
2817 1
3781 1
1618 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18797333 PACEMAKER LEAD FOR CERCLAGE PACING NGUYEN, VI X 3771 §103 Non-Final OA 28d overdue Pending Aug 07, 2024
18438563 APPARATUS AND METHOD FOR PREDICTING HYPOTENSION BASED ON ARTERIAL PRESSURE WAVELET TRANSFORMATION, AND METHOD FOR TRAINING HYPOTENSION PREDICTION MODEL NGUYEN, TRAN N 3685 §103 Final Rejection 17d overdue Pending Feb 12, 2024
18262341 STEM CELL IN WHICH IMMUNE CELL TOLERANCE MODULATOR IS OVEREXPRESSED, AND USE THEREOF PAULUS, ERIN VIRGINIA 1631 §103 Non-Final OA 20d Pending Jul 20, 2023
18352493 ARTIFICIAL BLOOD VESSEL COMPLEX WILLSE, DAVID H 3774 §103 Non-Final OA 14d Pending Jul 14, 2023
18249016 PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF RETINAL OR CHOROIDAL DISEASE COMPRISING PLVAP AS ACTIVE INGREDIENT YU, DELPHINUS DOU YI 1636 §112 Non-Final OA 23d Pending Apr 13, 2023
18004585 APPARATUS, METHOD, AND COMPUTER-READABLE STORAGE MEDIUM FOR SELECTING CLINICAL TRIAL SUBJECT HAYNES, DAWN TRINAH 3686 §103 Final Rejection 28d Pending Jan 06, 2023
18058956 NANOSTRUCTURE-BASED SUBSTRATE FOR SURFACE-ENHANCED RAMAN SPECTROSCOPY, AND MANUFACTURING METHOD THEREFOR LEE, DA WEI 2817 §103 Non-Final OA 4d overdue Pending Nov 28, 2022
18056766 RECTUM EXPANDING BALLOON CATHETER NGO, MEAGAN N 3781 §103 Non-Final OA 14d Pending Nov 18, 2022
17995024 STABILIZER FOR RADIOPHARMACEUTICALS AND RADIOPHARMACEUTICAL COMPOSITION COMPRISING THE SAME MEJIAS, SAMANTHA LEE 1618 §103 Non-Final OA 56d Pending Sep 29, 2022
17429343 BLOOD CELL-FREE DNA-BASED METHOD FOR PREDICTING PROGNOSIS OF LIVER CANCER TREATMENT SANFORD, DIANA PATRICIA 1687 §101 Non-Final OA 128d overdue Pending Aug 08, 2021
17153491 INFORMATION ACQUISITION METHOD USING HEART AND LUNG SOUNDS BAILEY, STEVEN WILLIAM 1687 §103 Non-Final OA 72d overdue Pending Jan 20, 2021

Managing UNIVERSITY OF ULSAN FOUNDATION FOR INDUSTRY COOPERATION's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month